Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal.

[1]  Jürgen Zentek,et al.  Review on sample preparation strategies and methods used for the analysis of aflatoxins in food and feed. , 2009, Molecular nutrition & food research.

[2]  B. Portmann,et al.  Microsatellite instability in hepatocellular carcinoma in non‐cirrhotic liver in patients older than 60 years , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  K. Boudjema,et al.  Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study. , 2009, World journal of gastroenterology.

[4]  P. Micheli,et al.  Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. , 2009, Journal of hepatology.

[5]  Manal M. Hassan,et al.  The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. , 2009, Journal of hepatology.

[6]  S. Kakar,et al.  Chromosomal changes in fibrolamellar hepatocellular carcinoma detected by array comparative genomic hybridization , 2009, Modern Pathology.

[7]  M. Neuhäuser,et al.  R0 Liver Resections for Primary Malignant Liver Tumors in the Noncirrhotic Liver: A Diagnosis-Related Analysis , 2009, Digestive Diseases and Sciences.

[8]  Li Xu,et al.  Clinicopathologic Features and Long-Term Outcomes of Chinese Patients with Hepatocellular Carcinoma in Non-Cirrhotic Liver , 2008, Digestive Surgery.

[9]  G. Qian,et al.  Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. , 2008, Journal of hepatology.

[10]  J. Hauss,et al.  Management of combined hepatocellular and cholangiocarcinoma , 2008, International journal of clinical practice.

[11]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[12]  M. Bartels,et al.  Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis. , 2008, Transplantation proceedings.

[13]  E. Hatano,et al.  Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. , 2007, Surgery.

[14]  Cristel G. Thomas,et al.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.

[15]  M. Kumar,et al.  Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case–control study of 213 hepatocellular carcinoma patients from India , 2007, Journal of gastroenterology and hepatology.

[16]  K. Schmitz,et al.  Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. , 2007, Journal of the American College of Surgeons.

[17]  M. Yuen,et al.  Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels , 2007, Gut.

[18]  M. Kudo,et al.  Antibody to Hepatitis B Core Antigen and Risk for Hepatitis CRelated Hepatocellular Carcinoma , 2007, Annals of Internal Medicine.

[19]  M. Scotté,et al.  Long-Term Outcome of Liver Resection for Hepatocellular Carcinoma in Noncirrhotic Nonfibrotic Liver with No Viral Hepatitis or Alcohol Abuse , 2007, World Journal of Surgery.

[20]  Y. L. Le Treut,et al.  Prognostic Factors After Resection for Hepatocellular Carcinoma in Nonfibrotic or Moderately Fibrotic Liver. A 116-Case European Series , 2007, Journal of Gastrointestinal Surgery.

[21]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[22]  A. Muratore,et al.  Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients--no mortality and long-term survival. , 2006, Hepato-gastroenterology.

[23]  Ding‐Shinn Chen,et al.  Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. , 2006, The Journal of infectious diseases.

[24]  Ronald A. DePinho,et al.  Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.

[25]  J. Zucman‐Rossi,et al.  Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC , 2006, Hepatology.

[26]  K. Batts,et al.  Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis , 2005, Modern Pathology.

[27]  K. Boudjema,et al.  Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. , 2005, Journal of the American College of Surgeons.

[28]  B. le Bail,et al.  Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. , 2005, Journal of the American College of Surgeons.

[29]  I. Okayasu,et al.  Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: Comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas , 2005, Pathology international.

[30]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[31]  D. Rudnick,et al.  CONCISE REVIEW IN MECHANISMS OF DISEASE Alpha-1-Antitrypsin Deficiency: A New Paradigm for Hepatocellular Carcinoma in Genetic Liver Disease , 2005 .

[32]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[33]  M. Sherman.  Hepatocellular carcinoma: epidemiology, risk factors, and screening. , 2005, Seminars in liver disease.

[34]  L. Bianchi.  Glycogen storage disease I and hepatocellular tumours , 2005, European Journal of Pediatrics.

[35]  T. Ide,et al.  Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon , 2005, Journal of Gastroenterology.

[36]  T. Liang,et al.  Pathogenesis of hepatitis C-associated hepatocellular carcinoma. , 2004, Gastroenterology.

[37]  Y. Imai,et al.  Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy , 2004, Cancer.

[38]  G. Chau,et al.  Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. , 2004, Archives of surgery.

[39]  H. El‐Serag,et al.  Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population‐based study , 2004, Hepatology.

[40]  H. Bismuth,et al.  Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers. , 2003, Carcinogenesis.

[41]  H. Bismuth,et al.  Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections , 2004, World Journal of Surgery.

[42]  A. Gardini,et al.  Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long‐term survival and tumour recurrence in a single centre , 2003, Alimentary pharmacology & therapeutics.

[43]  J. Quinn,et al.  Fibrolamellar hepatocellular carcinoma in children and adolescents , 2003, Cancer.

[44]  L. Jeng,et al.  Prognostic Factors after Resection for Hepatocellular Carcinoma in Noncirrhotic Livers: Univariate and Multivariate Analysis , 2003, World Journal of Surgery.

[45]  S. Thorgeirsson,et al.  Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China , 2002, Hepatology.

[46]  R. Warren,et al.  Thorotrast-induced liver neoplasia: a collective review. , 2002, Journal of the American College of Surgeons.

[47]  K. Okuda.  Natural history of hepatocellular carcinoma including fibrolamellar and hepato‐cholangiocarcinoma variants , 2002, Journal of gastroenterology and hepatology.

[48]  A. Tannapfel,et al.  Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis , 2002, Virchows Archiv.

[49]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[50]  N. Nagasue,et al.  Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis , 2001, The British journal of surgery.

[51]  K. Sugimachi,et al.  The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. , 2000, Journal of the American College of Surgeons.

[52]  P. Pineau,et al.  Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases , 2000, Hepatology.

[53]  K. Meyer,et al.  Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. , 2000, Virology.

[54]  R. Poon,et al.  Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  J. Park,et al.  Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. , 2000, Biochemical and biophysical research communications.

[56]  S. Chevret,et al.  Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. , 1999, Journal of hepatology.

[57]  Yasuyuki Arakawa,et al.  Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan , 1999, Annals of Internal Medicine.

[58]  J. McCall,et al.  Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[59]  A. Andriulli,et al.  Characteristics of hepatocellular carcinoma in Italy. , 1998, Journal of hepatology.

[60]  H. Fischer,et al.  Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. , 1998, The American journal of surgical pathology.

[61]  T. DeNapoli,et al.  Hepatocellular Carcinoma in Children Associated With Gardner Syndrome or Familial Adenomatous Polyposis , 1998, Journal of pediatric hematology/oncology.

[62]  S. Todo,et al.  Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation , 1997, Hepatology.

[63]  F. Bosman,et al.  Germ‐line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma , 1997, Hepatology.

[64]  Akriviadis Ea.  Hemoperitoneum in patients with ascites. , 1997 .

[65]  F. Lithner,et al.  The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria , 1996, Journal of internal medicine.

[66]  H. Hsu,et al.  Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. , 1996, Surgery.

[67]  K. Ishak,et al.  Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. , 1996, The American journal of gastroenterology.

[68]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[69]  S. Khakoo,et al.  HCV-associated hepatocellular carcinoma without cirrhosis. , 1996, Journal of hepatology.

[70]  K. Ishak,et al.  Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. , 1996, American journal of clinical pathology.

[71]  M. Vivarelli,et al.  Ruptured hepatocellular carcinoma: an important cause of spontaneous haemoperitoneum in Italy. , 1995, The European journal of surgery = Acta chirurgica.

[72]  P. Brissot,et al.  Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver , 1995, Hepatology.

[73]  T. Takegami,et al.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells , 1995, Journal of virology.

[74]  M. Bernardi,et al.  Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patient , 1995, Cancer.

[75]  P. Pontisso,et al.  HCV-associated liver cancer without cirrhosis , 1995, The Lancet.

[76]  T. Ulbright,et al.  Hepatocellular carcinoma arising in congenital hepatic fibrosis. , 1994, The American journal of gastroenterology.

[77]  M. Makuuchi,et al.  Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases. , 1994, The American journal of gastroenterology.

[78]  C. Milgrom,et al.  A REPORT OF FOUR CASES , 1994 .

[79]  B. Henderson,et al.  A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[80]  R. Esteban,et al.  [Hepatocellular carcinoma: clinical aspects, diagnosis, and survival in 140 cases]. , 1993, Medicina clinica.

[81]  P. Brissot,et al.  Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases. , 1993, Gastroenterology.

[82]  C. Wittekind,et al.  Results of hepatic resection and transplantation for fibrolamellar carcinoma. , 1992, Surgery, gynecology & obstetrics.

[83]  H. Koyama,et al.  Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. , 1992, Surgery.

[84]  H. Adami,et al.  Alcoholism and liver cirrhosis in the etiology of primary liver cancer , 1992, International journal of cancer.

[85]  N. Kemeny,et al.  Type la glycogenosis associated with hepatocellular carcinoma , 1992 .

[86]  R. Purcell,et al.  Etiology, pathology, and treatment of hepatocellular carcinoma in North America , 1991 .

[87]  S. Davies,et al.  Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver. , 1991, Journal of hepatology.

[88]  B. le Bail,et al.  Late recurrence of a hepatocellular carcinoma in a patient with incomplete Alagille syndrome. , 1990, Gastroenterology.

[89]  M. Kew.  Pathogenesis of hepatocellular carcinoma in hereditary hemochromatosis: Occurrence in noncirrhotic patients , 1990 .

[90]  J. Bruix,et al.  Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. , 1990, Journal of hepatology.

[91]  M. Matsumoto,et al.  Promoting effect of citrulline in hepatocarconogenesis: Possbile mechanism in hypercitrullinemia , 1990, Hepatology.

[92]  K. Muczynski,et al.  Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma , 1989, Cancer.

[93]  M. Kojiro,et al.  Hepatocellular carcinoma without cirrhosis in Japanese patients. , 1989, Gastroenterology.

[94]  L. Melton,et al.  Hepatoma in the noncirrhotic liver , 1988, Cancer.

[95]  M. Makuuchi,et al.  Safety of hemihepatic vascular occlusion during resection of the liver. , 1987, Surgery, gynecology & obstetrics.

[96]  D. Forman,et al.  Cancer of the liver and the use of oral contraceptives. , 1986, British medical journal.

[97]  D. Forman,et al.  Oral contraceptives and hepatocellular carcinoma. , 1986, British medical journal.

[98]  H. Popper,et al.  Relationship Between Hepatocellular Carcinoma and Cirrhosis , 1984, Seminars in liver disease.

[99]  K. Okuda,et al.  Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: A comparative study of histopathology and frequency of hepatitis B markers , 1982, Cancer.

[100]  M. Omata,et al.  Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico‐pathologic features , 1980, Cancer.

[101]  H. Kronenberg,et al.  ANDROGEN-INDUCED HEPATOMA , 1975, The Lancet.

[102]  P. Majerus,et al.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. , 1972, Lancet.

[103]  W. Manion,et al.  Vascular lesions in women taking oral contraceptives. , 1970, Archives of pathology.